MA23412A1 - Procede pour preparation de glycosides steroidiens , utiles comme agents hypocholesterolemiques et agents anti atherosclereux - Google Patents

Procede pour preparation de glycosides steroidiens , utiles comme agents hypocholesterolemiques et agents anti atherosclereux

Info

Publication number
MA23412A1
MA23412A1 MA23741A MA23741A MA23412A1 MA 23412 A1 MA23412 A1 MA 23412A1 MA 23741 A MA23741 A MA 23741A MA 23741 A MA23741 A MA 23741A MA 23412 A1 MA23412 A1 MA 23412A1
Authority
MA
Morocco
Prior art keywords
agents
atherosclereous
useful
preparation
hypocholesterolemic
Prior art date
Application number
MA23741A
Other languages
English (en)
Inventor
Paul Denimmo Michael
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA23412A1 publication Critical patent/MA23412A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
MA23741A 1993-12-28 1994-12-27 Procede pour preparation de glycosides steroidiens , utiles comme agents hypocholesterolemiques et agents anti atherosclereux MA23412A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17410093A 1993-12-28 1993-12-28

Publications (1)

Publication Number Publication Date
MA23412A1 true MA23412A1 (fr) 1995-07-01

Family

ID=22634820

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23741A MA23412A1 (fr) 1993-12-28 1994-12-27 Procede pour preparation de glycosides steroidiens , utiles comme agents hypocholesterolemiques et agents anti atherosclereux

Country Status (11)

Country Link
US (1) US5698526A (fr)
EP (1) EP0737203A1 (fr)
AU (1) AU7948494A (fr)
CA (1) CA2180149A1 (fr)
CO (1) CO4230021A1 (fr)
FI (1) FI946106L (fr)
HR (1) HRP941012A2 (fr)
IL (1) IL112117A0 (fr)
MA (1) MA23412A1 (fr)
PE (1) PE49295A1 (fr)
WO (1) WO1995018144A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI970828L (fi) * 1994-08-30 1997-02-27 Pfizer Spirostanyyliglykosidien kiteitä
WO1996038466A1 (fr) * 1995-05-29 1996-12-05 Pfizer Inc. Glycosides steroidiques
US5698527A (en) * 1995-08-08 1997-12-16 Merck & Co., Inc. Steroidal glycosides as antihyperlipidemic agents
PL195897B1 (pl) * 1998-03-26 2007-11-30 Phytopharm Plc Zastosowanie smilageniny
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
US6635490B1 (en) 2000-05-25 2003-10-21 Noble Laboratories Procedure for the simultaneous quantitative and qualitative analysis of both flavonoid glycosides and steroidal glycosides
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
KR101646960B1 (ko) 2007-10-16 2016-08-09 프로젠 피지500 시리즈 피티와이 리미티드 신규한 황산화된 올리고사카라이드 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024624A (en) * 1978-07-05 1980-01-16 Roecar Holdings Nv Anti inflammatory spiroketalins
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
EP0647233A1 (fr) * 1992-06-26 1995-04-12 Pfizer Inc. PROCEDE DE SYNTHESE DE $g(b)-O-CELLOBIOSIDE HEPTAALCANOATE STEROIDIEN

Also Published As

Publication number Publication date
CA2180149A1 (fr) 1995-07-06
FI946106A0 (fi) 1994-12-27
CO4230021A1 (es) 1995-10-19
WO1995018144A1 (fr) 1995-07-06
HRP941012A2 (en) 1997-08-31
IL112117A0 (en) 1995-03-15
AU7948494A (en) 1995-07-17
FI946106A7 (fi) 1995-06-29
PE49295A1 (es) 1996-01-09
EP0737203A1 (fr) 1996-10-16
US5698526A (en) 1997-12-16
FI946106L (fi) 1995-06-29

Similar Documents

Publication Publication Date Title
IL117188A0 (en) Process for the preparation of thietanones
SG55239A1 (en) Process for the preparation of dihaloazpyrimidines
MA23411A1 (fr) Procede de preparation de glycosides steroidiens servant d'agents hypocholesterolemique et anti atherosclereux.
MA23412A1 (fr) Procede pour preparation de glycosides steroidiens , utiles comme agents hypocholesterolemiques et agents anti atherosclereux
AU4436596A (en) Process for the production of liquid compositions
EP0833814A4 (fr) Procede de preparation d'hydroxyalkylamides
AU1230595A (en) Process for the preparation of polyalkyl-1-oxa- diazaspirodecane compounds
AU6243390A (en) Process for improving the cold formability of heat-treatable steels
AU4259296A (en) Process for preparation of supports
MA23900A1 (fr) Procede pour la preparation de compositions antiretrovirale
AU7930494A (en) Intermediate and process for making
SG67349A1 (en) Process for the hydroxycarbonylation of butadiene
NO964482D0 (no) Fremgangsmåte ved fremstilling av doxorubicin
AU6866394A (en) Method for producing liquid fertilizer
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
AU7696394A (en) Process for the preparation of alkylglycosides
AU2760595A (en) Process for stainless steel pickling
FR2728268B1 (fr) Procede de preparation de gamma-cyclodextrine
AU3507495A (en) Process for the stereoselective reduction of steroid enelactams
EP0823904A4 (fr) Procede de preparation de spiroindolines
AU5322296A (en) Compositions and process for treating hemangioma
AU6062796A (en) The process of asphalt purification and the composition of modified asphalt
AU6051796A (en) Process for the continuous manufacture of steel
IL125004A0 (en) Process for the preparation of 9,11 beta-epoxide steroids
AU5645796A (en) Process for the purification of glycoproteins like erythropoietin